UAMS Principal Investigator: Sanjeeva Onteddu, M.D., is an associate professor in the College of Medicine Department of Neurology.
Summary: The “Zeit Alert for Stroke at Home (ZASH)” study is a multi-center clinical trial evaluating the Halo Alert System to determine if the device can be used to detect strokes. The device, worn as a headband, is designed for patients who return home from hospitalization after stroke and are at high risk for future strokes.
Significance: If the current study determines the device can effectively and safely detect stroke, a future study would test its ability to provide alerts at the onset of a stroke, potentially life-saving warnings for patients and their families.
TRI Services: Medicare coverage analysis, study budget development, administration of Clinical Trial Management System, clinical research coordinator support, and post-award financial management.
Sponsor: Zeit Medical